Latest In: Sativex

Bayer Canada Epidiolex GW Pharmaceuticals Jazz Pharmaceuticals Canada Sativex
Image of a machine filling bottles with Epidiolex

Cannabinoid-based medicine Epidiolex approved for sale in Canada

Canada's federal health regulator has approved Jazz Pharmaceuticals Canada's cannabinoid-based medicine Epidiolex as an adjunctive therapy for certain…

News November 30
Epidolex German cannabis insurance German National Association of Statutory Health Insurance Funds Germany GKV-Spitzenverband Sativex
Image of a pile of euros

Germany’s cannabis insurance payouts hit 51 million euros in first quarter

Insurance reimbursements for medical cannabinoid products in Germany continued to grow in the first quarter of 2023, showing…

News August 17
aurora cannabis Canopy Dronabinol Europe European Union Germany Sativex Tilray

Insurance-covered reimbursements for medical cannabis sets record in Germany

Insurance reimbursements for medical cannabis in Germany continue to reach fresh quarterly records, according to new data for…

News June 19
Get MJBizDaily, the newsletter that gives you an edge in the rapidly changing cannabis industry.
Australia Emerge Health GW Pharmaceuticals New Zealand Sativex United Kingdom

New Zealand eases prescription requirement for cannabis-based medicine Sativex

Doctors in New Zealand no longer require Ministry of Health approval to prescribe Sativex, according to a new…

News April 9
Australia cannabidiol Epidiolex GW Pharma Sativex

Australia expedites review of medical cannabis product Epidiolex

The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another.

News January 30
Epidiolex GW Pharmaceuticals Sativex

GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug

A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana.

News January 13
bedrocan C3 Canopy Growth Cronos Dronabinol German National Association of Statutory Health Insurance Funds Germany GKV-Spitzenverband Portugal Sativex TerrAscend Tilray wayland

Analysis: Germany’s medical cannabis market loses momentum but on pace to surpass 100 million euros

Insurance reimbursements for medical cannabis in Germany reached a new high during the July-September period, according to recently published data by…

News December 18
Epidiolex nabilone Sativex

New UK guidelines recommend public insurance coverage for two GW Pharma cannabis medicines, plus a synthetic cannabinoid

New British guidelines for the first time recommend that two plant-based cannabis medicines – Sativex and Epidiolex –…

News November 12
ANVISA Brazil Entourage Brazil Good Manufacturing Practices Mevatyl Onixcann Brazil Sativex

Breakthrough in Brazil: Regulators eye domestic cannabis cultivation, creation of product registration plan

Brazil could become the latest country to regulate the domestic cultivation of medical cannabis, according to the government…

News June 17
MJBizCon Logo